About
Biopolymer treatments against conditions involving metals toxicity
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
38
By Phase
NA: 3
By Status
RECRUITING: 1TERMINATED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06340269Lead Sponsor
Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in ACLF
NARecruiting
10 participants
Started: Jun 21, 2024 · Completed: Oct 31, 2025
NCT06150404Collaborator
A Randomized Controlled Trial to Evaluate the Effect of White Noises and Parental Voices As Protectors Against Noise Damage in a Neonatal Intensive Care Unit
NATerminated
11 participants
Started: Feb 1, 2024 · Completed: Dec 31, 2024
NCT05917327Lead Sponsor
Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease
NAActive, not recruiting
17 participants
Started: Jan 24, 2024 · Completed: Apr 1, 2026
Locations (1)
Headquarters
Villeurbanne, France
Map
Loading map...